EvoNexus’ Post

🎤 Today we announced the discovery of a novel cryptic human proteome and $4M pre-seed financing! To learn more, see our press release below. 😯 We discovered more than 8,000 previously unidentified peptides on the surface of cells. About 1,000 of these appear to be specific to cancer cells making them ideal therapeutic targets! ❤️🩹👩⚕️ The funds will be used to develop first-in-class cancer immunotherapies towards these druggable "dark" therapeutic targets 💉 Special thanks to our fantastic investors Genedant Capital, SeaX Ventures, SOSV, Swell VC, Phase Two Ventures, and WS Investments as well as our awesome angels! Also, a shoutout to Oregon Health & Science University, IndieBio, EvoNexus, and Nucleate for their support. We also appreciate the coverage by The Wall Street Journal, Fortune and Endpoints News in their newsletters! 🙏 Corey Dambacher, Imad Ajjawi, PhD, MBA, Ashley Woodfin, Alex Jaeger, Kerry Wilson, Joseph Estabrook, Jessica Weir #darkgenome #cancerimmunotherapies #drugdiscovery #darkproteome #immunotherapies https://lnkd.in/g5aCuWzt